shortagewatch

Home / Cancer and immune system / Everolimus

ATC L04AH02 · Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors · updated 2 Nov 2026

Everolimus shortage

As of 2 Nov 2026, Everolimus has a reported shortage in 1 of the 16 countries we track (Canada), covering 4 products from 2 companies.

Is there an Everolimus shortage?

Yes. As of 2 Nov 2026, Everolimus is reported short in 1 of the 16 countries we track: Canada. The earliest expected return is 10 Aug 2027 (Canada). 3 of 4 affected products have no return date. New since 3 Oct 2026: Canada.

Countries1/16
Products4packs or presentations
Companies22 listed
Short since10 Jan 20242.8 years ago
Earliest return10 Aug 2027company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada4 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Canada
20252026TEVA-EVEROLIMUS (30)TEVA-EVEROLIMUS (30)AFINITOR (3 blister strips of 10)AFINITOR (3 blister strips of 10)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Novartis3 NOVNTeva1 TEVA

Listed: Teva TEVA · NYSE / TASE, Novartis NOVN · SIX Swiss

Affected products

CountryProductCompanySinceExpected backReason
CATEVA-EVEROLIMUS (30)TEVA CANADA LIMITED10 Jan 202410 Aug 2027Manufacturing problem
Disruption of the manufacture of the drug
CAAFINITOR (3 blister strips of 10)NOVARTIS PHARMACEUTICALS CANADA INC26 Oct 2026not givenManufacturing problem
Disruption of the manufacture of the drug
CAAFINITOR (3 blister strips of 10) anticipatedNOVARTIS PHARMACEUTICALS CANADA INC31 Dec 2026not givenManufacturing problem
Disruption of the manufacture of the drug
CAAFINITOR (3 blister strips of 10) anticipatedNOVARTIS PHARMACEUTICALS CANADA INC31 Dec 2026not givenManufacturing problem
Disruption of the manufacture of the drug

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there an Everolimus shortage?

Yes. As of 2 Nov 2026, Everolimus is reported short in 1 of the 16 countries we track: Canada. The earliest expected return is 10 Aug 2027 (Canada). 3 of 4 affected products have no return date. New since 3 Oct 2026: Canada.

When will Everolimus be back in stock?

Companies expect supply back from 10 Aug 2027 in Canada; Canada: 10 Aug 2027. These are company estimates reported to each authority.

Why is Everolimus in short supply?

The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.

Which companies have Everolimus shortages?

Novartis, Teva.